Lee F T, Boniface G R, Lambrecht R M, Rylatt D B, Bundesen P G
Biomedicine and Health Program, Australian Nuclear Science and Technology Organisation, Menai, New South Wales.
Immunol Cell Biol. 1993 Apr;71 ( Pt 2):117-24. doi: 10.1038/icb.1993.12.
The antifibrin DD-3B6/22 monoclonal antibody Fab' fragment, a murine immunoglobulin, IgG3, has been labelled with technetium-99 m (99mTc) via a transchelation reaction, to specific activity in excess of 30 mCi/mg protein. The radiolabelling of Fab' was dependent on time, temperature, pH, antibody concentrations and nature of intermediary transchelation complex used. The resultant radioconjugate was stable in vitro and in vivo. Blood clearance of 99mTc-Fab' in rat followed two compartment kinetics with the half time of the fast phase being 0.5 h. The main route of excretion was via the kidneys with little uptake indicated by other tissues. The results suggest that the inherent specificity of the antibody, small molecular size, rapid plasma clearance, high specific radioactivity, together with the physical properties of the 99mTc label, combine to make this labelled monoclonal antibody (MoAb), potentially suitable as a radiopharmaceutical for the scintigraphic detection of thrombi in humans.
抗纤维蛋白DD - 3B6/22单克隆抗体Fab'片段,一种鼠免疫球蛋白IgG3,已通过转螯合反应用锝 - 99m(99mTc)标记,比活度超过30 mCi/mg蛋白。Fab'的放射性标记取决于时间、温度、pH值、抗体浓度以及所用中间转螯合复合物的性质。所得放射性缀合物在体外和体内均稳定。大鼠体内99mTc - Fab'的血液清除遵循双室动力学,快相半衰期为0.5小时。主要排泄途径是通过肾脏,其他组织摄取较少。结果表明,抗体的固有特异性、小分子大小、快速的血浆清除率、高比放射性,以及99mTc标记的物理性质,共同使得这种标记的单克隆抗体(MoAb)有可能适合作为一种放射性药物用于人体血栓的闪烁显像检测。